1 A study
was excluded if (
1) more than 25% of participants were n
2 Patients
were excluded if 5-FU was used as adjuvant therapy, if t
3 Patients
were excluded if a definitive diagnosis of FEVR could no
4 Patients
were excluded if a diagnosis of FEVR could not be made.
5 Studies
were excluded if: (
a) they used mixed methods where qual
6 Potential cases
were excluded if all pertinent donors tested negative.
7 Patients
were excluded if any of the following red flag symptoms
8 Patients
were excluded if any surgery had been performed at an ou
9 Studies
were excluded if at least 1 study arm did not have ascor
10 Patients
were excluded if at least one of the following condition
11 Patients
were excluded if baseline K(+) was >5.0 mEq/L or serum c
12 Patients
were excluded if body mass index had changed more than 1
13 Infants
were excluded if born under 32 weeks, with a serious ill
14 Studies
were excluded if case definition was not clearly defined
15 Eyes
were excluded if central corneal thickness (CCT) or Ocul
16 Patients
were excluded if cirrhosis, other chronic liver disease,
17 Patients
were excluded if data on flap type or clinical demograph
18 postoperative day 0 were included; patients
were excluded if data required to determine frailty, est
19 Participants
were excluded if dates did not overlap with the study pe
20 For LASSO analysis, samples
were excluded if gene expression data were not obtained
21 Patients
were excluded if headache had lasted more than 3 days or
22 rule-out pathway where myocardial infarction
was excluded if high-sensitivity cardiac troponin I conc
23 (> or =28 d) of each study were analyzed and
were excluded if individual intakes of calcium, copper,
24 Data
were excluded if individual intakes of magnesium, copper
25 Patients
were excluded if infarcts were located in both the anter
26 Children
were excluded if iron supplement use occurred within the
27 ing of article titles and abstracts, studies
were excluded if irrelevant to the topic of this systema
28 A symptom would
be excluded if it occurred in the year prior to infectio
29 ast a 6-month follow-up period, and patients
were excluded if it was determined that intrathoracic re
30 Trials
were excluded if limited to participants older than 65 y
31 Eyes
were excluded if LTP laterality or baseline intraocular
32 cluding one child younger than 18 years, and
were excluded if more than half of household members dec
33 Studies
were excluded if MSM could not be distinguished from men
34 Studies
were excluded if mupirocin was not used for decolonizati
35 Residents
were excluded if one or more of the test scores were not
36 Studies
were excluded if participants had eating disorders, prio
37 Studies
were excluded if participants were exclusively HIV-infec
38 Articles
were excluded if patients did not precisely fit any exis
39 ients >12 h and up to 60 days after AMI, and
were excluded if patients were hemodynamically unstable.
40 Patients
were excluded if patients: (1) were screened by an outsi
41 Patients
were excluded if PH was secondary to left heart disease,
42 SSc patients
were excluded if previously treated with rituximab, intr
43 Individuals
were excluded if receiving medications other than metfor
44 Articles
were excluded if reporting only intermediate outcomes (e
45 Articles
were excluded if study duration was <1 year, <3 spiromet
46 Patients
were excluded if surgery was bilateral or combined with
47 Participants
were excluded if taking antibiotics in the past 2 months
48 Patients
were excluded if temperature or route of temperature mea
49 Participants
were excluded if tested positive on urine drug screen (e
50 HBeAg-negative chronic hepatitis would also
be excluded if testing were only performed at presentati
51 only performed at presentation and 30% would
be excluded if testing were performed on 3 occasions.
52 e dominant competitor over some of its range
being excluded if the area where it is dominant is too s
53 Non-English reports
were excluded if the abstract did not include enough inf
54 Patients
were excluded if the amyloid diagnosis preceded the tran
55 Observations
were excluded if the appointment was booked before but c
56 Studies
were excluded if the article was an unpublished disserta
57 Patients
were excluded if the attending surgeon had less than 24
58 Primary care institutions
were excluded if the catchment area had fewer than 100 p
59 Articles
were excluded if the cause of hepatitis was ambiguous or
60 Emergency department visits
were excluded if the Clinical Classifications Software c
61 Studies
were excluded if the duration was less than 6 months or
62 Patients
were excluded if the initial surgery included rhinoplast
63 Patients
were excluded if the left common carotid or brachiocepha
64 Mother-infant pairs
were excluded if the mothers intended to attend well-bab
65 Responses
were excluded if the participant was not able to define
66 Studies
were excluded if the population was selected according t
67 Studies
were excluded if the sample contained fewer than 20 part
68 Studies
were excluded if the sample was not representative of th
69 Studies
were excluded if the severity of TBI among participants
70 They
were excluded if the use of compression stockings was co
71 Patients
were excluded if their baseline serum creatinine was >1.
72 Patients
were excluded if their CABG surgery was combined with an
73 Patients
were excluded if their original consent forms to report
74 Local authorities
were excluded if their populations were too small or if
75 Patients
were excluded if their sequential visual fields showed a
76 Participants
were excluded if there was a comorbidity that could acco
77 Subjects
were excluded if there were medications or systemic or n
78 Studies
were excluded if they (1) failed to use VBM, (2) failed
79 Studies
were excluded if they 1) included both pharmacological a
80 Studies
were excluded if they assessed only individuals with kno
81 Trials
were excluded if they assessed the trackers only as meas
82 Eyes
were excluded if they averaged fewer than 6.5 injections
83 Articles
were excluded if they combined Indigenous and non-Indige
84 Lesions
were excluded if they contained necrotic components or w
85 Patients
were excluded if they could not receive curative surgery
86 Articles
were excluded if they dealt with pediatrics, geriatrics,
87 People
were excluded if they declined consent, were severely il
88 Patients
were excluded if they declined to participate, could not
89 Studies
were excluded if they described treatment of cervical gl
90 Responders
were excluded if they did not complete at least 1 health
91 Articles
were excluded if they did not contain a cohort with Alzh
92 Articles
were excluded if they did not contain data on a p-tau bl
93 Posts
were excluded if they did not discuss 1 of the 5 tests o
94 Studies
were excluded if they did not evaluate colorectal screen
95 Studies
were excluded if they did not feature a clearly positive
96 Studies
were excluded if they did not focus on women with a prim
97 Articles
were excluded if they did not focus specifically on the
98 Patients
were excluded if they did not have >= 6 months of follow
99 Patients
were excluded if they did not have a known subtype or a
100 Patients
were excluded if they did not have a preoperative target
101 Patients
were excluded if they did not have at least 365 days for
102 Patients
were excluded if they did not have continuous insurance
103 Participants
were excluded if they did not have longitudinal data, ap
104 Articles
were excluded if they did not include any women living w
105 of reproductive age were considered; studies
were excluded if they did not include individual-level p
106 Members
were excluded if they did not meet eligibility criteria,
107 For the primary key question, articles
were excluded if they did not provide a comparator as ke
108 Patients
were excluded if they did not receive a carbapenem after
109 tients (aged >/=60 years) with GBM; articles
were excluded if they did not report survival data from
110 Studies
were excluded if they did not specify viral load thresho
111 Studies
were excluded if they did not use a gamified DMHI, provi
112 Studies
were excluded if they did not use a laboratory-based com
113 to pre-DCR implementation and DCR groups and
were excluded if they died before completion of the init
114 Patients
were excluded if they died before the tobacco treatment
115 Patients
were excluded if they died on arrival or in the emergenc
116 Patients
were excluded if they died within 72 hours.
117 Studies
were excluded if they enrolled pediatric patients, patie
118 Participants
were excluded if they exhibited performance outside the
119 Subjects
were excluded if they experienced other changes in their
120 Articles
were excluded if they focused solely on contrast agents,
121 Patients
were excluded if they had 20 or more fistulae at baselin
122 Patients
were excluded if they had a baseline diagnosis of depres
123 Patients
were excluded if they had a contraindication to prophyla
124 Caregivers
were excluded if they had a diagnosed and untreated ment
125 Patients
were excluded if they had a documented dose of SARS-CoV-
126 Patients
were excluded if they had a family history of parental c
127 Subjects
were excluded if they had a history of a myocardial infa
128 Patients
were excluded if they had a history of asymptomatic DVT,
129 Patients
were excluded if they had a history of congenital or acq
130 Patients
were excluded if they had a history of deep vein thrombo
131 Persons
were excluded if they had a history of gout or had recei
132 Participants
were excluded if they had a history of or had received t
133 Patients
were excluded if they had a history of proliferative dis
134 Patients
were excluded if they had a history of retinal artery oc
135 Patients
were excluded if they had a history of significant shoul
136 Soldiers
were excluded if they had a medical or psychiatric condi
137 Patients
were excluded if they had a preexisting cardiac arrhythm
138 Females
were excluded if they had a previous cancer diagnosis (e
139 Subjects
were excluded if they had a previous diagnosis of chroni
140 Patients
were excluded if they had a previous revascularization.
141 Patients
were excluded if they had a stroke or MI within 2 years
142 Patients
were excluded if they had a structural cerebral cause fo
143 f they had current urinary incontinence, and
were excluded if they had a third degree or higher uteri
144 Patients
were excluded if they had active brain metastases or act
145 Patients
were excluded if they had acute viral croup, tracheal su
146 Participants
were excluded if they had allergy to rice; history of ch
147 Patients
were excluded if they had an absolute contraindication t
148 Patients
were excluded if they had an interval of more than 1 yea
149 Patients
were excluded if they had an open abdomen treatment in t
150 Patients
were excluded if they had another diagnosis meriting PC,
151 at least 4 months before randomisation; they
were excluded if they had another premorbid speech and l
152 Patients
were excluded if they had anti-CD38 refractory disease o
153 Newborns
were excluded if they had any evidence of another congen
154 ET/CT and dedicated CT scans within 6 wk and
were excluded if they had any intervention between scans
155 Patients
were excluded if they had any of these events before the
156 Individuals
were excluded if they had any previous prostate biopsy,
157 Women
were excluded if they had any signs of active cancer or
158 Participants
were excluded if they had at least one low coverage samp
159 Participants
were excluded if they had been born prematurely (<37 wee
160 Subjects
were excluded if they had cardiac, pulmonary, liver, or
161 Patients
were excluded if they had cataract surgery during the st
162 Participants
were excluded if they had central nervous system infecti
163 Patients
were excluded if they had cognitive disabilities prevent
164 Patients
were excluded if they had comorbidities that associate w
165 Participants
were excluded if they had conditions affecting growth (e
166 People
were excluded if they had COVID-19 before baseline.
167 Individuals
were excluded if they had dementia or metastatic cancer,
168 Women
were excluded if they had depression within 24 months be
169 Volunteers
were excluded if they had eczema, psoriasis, or other ch
170 Patients
were excluded if they had evidence of HCV genotype or su
171 Participants
were excluded if they had evidence of neurologic or addi
172 Infants
were excluded if they had existing risk factors for neur
173 Patients
were excluded if they had foot, hand, and wrist metastas
174 Potential subjects
were excluded if they had had previous glaucoma surgery
175 Patients
were excluded if they had HDV superinfection, liver infe
176 Patients
were excluded if they had history of stroke, MI, DVT, or
177 Patients
were excluded if they had hypotension, defined as either
178 Patients
were excluded if they had implantable cardioverter defib
179 Participants
were excluded if they had ischaemic pain or tissue loss
180 Patients
were excluded if they had less than 3 months of follow-u
181 Patients
were excluded if they had less than 3 months of follow-u
182 Participants
were excluded if they had missing data for blood pressur
183 Subjects
were excluded if they had moderate or high levels of ant
184 Patients
were excluded if they had more than 1 procedure during a
185 Patients
were excluded if they had multi-organ transplant or hosp
186 Participants
were excluded if they had multiple myeloma or any other
187 Participants
were excluded if they had neurological comorbidities tha
188 Patients
were excluded if they had no follow-up within 3 months o
189 Participants
were excluded if they had no PCR tests after enrolment,
190 Individuals
were excluded if they had not been in the health-care sy
191 Patients
were excluded if they had not completed breast mound rec
192 Patients
were excluded if they had one or more of the following d
193 Patients
were excluded if they had poorly controlled diabetes, pr
194 Potential participants
were excluded if they had previous experience with any o
195 Patients
were excluded if they had previous thyroid or neck surge
196 Patients
were excluded if they had previously had radiotherapy or
197 Patients
were excluded if they had previously undergone B-KPro im
198 Patients
were excluded if they had prophylactic mastectomy; delay
199 Patients
were excluded if they had received a non-standard single
200 Patients
were excluded if they had received a previous kidney tra
201 Participants
were excluded if they had received any of the trial vacc
202 Participants
were excluded if they had received more than 24 h of tre
203 Patients
were excluded if they had received previous treatment wi
204 Lesions
were excluded if they had solid enhancing components.
205 Patients
were excluded if they had stage 2 hypertension or known
206 They
were excluded if they had symptomatic brain metastases o
207 Patients
were excluded if they had systolic pulmonary artery pres
208 Patients
were excluded if they had unreliable VFs (fixation losse
209 Patients
were excluded if they had upper urinary tract disease, u
210 Studies
were excluded if they included only healthy volunteers,
211 PG cases
were excluded if they included PG only as a part of the
212 Studies
were excluded if they investigated malignant lesions or
213 Studies
were excluded if they involved fewer than 10 patients, w
214 Studies
were excluded if they involved nonhospitalized, pediatri
215 Articles
were excluded if they lacked a study population, used ar
216 Persons
were excluded if they lacked follow-up PET scans.
217 Studies
were excluded if they lacked full text, reported clinica
218 Studies
were excluded if they lacked full text, reported results
219 Individuals
were excluded if they lived in an urban setting, were ou
220 CHR subjects
were excluded if they met criteria for bipolar I disorde
221 Patients
were excluded if they never developed sepsis, if the ICU
222 Patient cases
were excluded if they occurred outside the prespecified
223 Patients
were excluded if they opted out this service after the i
224 Patients
were excluded if they presented with a ST-elevation myoc
225 People
were excluded if they presented with both shoulders disl
226 Patients
were excluded if they received a deceased donor liver tr
227 Patients
were excluded if they received a deceased donor LT.
228 Patients
were excluded if they received anticoagulation before su
229 Participants
were excluded if they received hematopoietic cell transp
230 Eyes
were excluded if they received intraocular injections, l
231 Patients
were excluded if they received more than 2 red blood cel
232 Patients
were excluded if they refused to participate, had altern
233 Studies
were excluded if they reported data concerning people li
234 Studies
were excluded if they reported only intermediate physiol
235 Articles
were excluded if they reported results from A(H5N1) sero
236 Participants
were excluded if they reported using any form of tobacco
237 Patients
were excluded if they required a thoracoscopy for diagno
238 Children
were excluded if they required hospitalization, had como
239 allowed stable doses of corticosteroids but
were excluded if they required increasing amounts of cor
240 Individuals
were excluded if they resided in apartments missing suit
241 In addition, individuals
were excluded if they self-reported as having other than
242 Lungs
were excluded if they showed any mismatched V/Q defect o
243 Advertisements
were excluded if they targeted businesses rather than co
244 G1691A and prothrombin G20210A mutation and
were excluded if they tested positive.
245 Studies
were excluded if they treated individuals with HIV/AIDS
246 Individuals
were excluded if they underwent intraocular surgery duri
247 Patients
were excluded if they underwent resection within 1 year
248 Studies
were excluded if they used self-reported outcomes or exa
249 Children
were excluded if they were admitted to the PICU for prim
250 Children
were excluded if they were born at a gestational age of
251 Patients
were excluded if they were coagulopathic, had no suitabl
252 Participants
were excluded if they were concurrently enrolled in othe
253 Studies
were excluded if they were conducted exclusively among p
254 Studies
were excluded if they were conducted outside of the US,
255 Patients
were excluded if they were currently taking 2 or more bl
256 Patients
were excluded if they were declared brain dead, were org
257 f they remained in ICU for over 24 hours and
were excluded if they were delirious on ICU admission, o
258 Studies
were excluded if they were delivered at the community or
259 LS by revised El Escorial criteria; controls
were excluded if they were diagnosed as having ALS or an
260 Studies
were excluded if they were duplicate cohorts, had insuff
261 Physicians
were excluded if they were in training, worked primarily
262 From this set, IRs
were excluded if they were in unfinished/unassembled reg
263 Patients
were excluded if they were incontinent or impotent preop
264 Participants
were excluded if they were intubated, transferred for ur
265 Studies
were excluded if they were limited to nosocomial, chroni
266 Tumors
were excluded if they were metastatic at presentation or
267 Participants
were excluded if they were missing any of the 9 postmort
268 Patients
were excluded if they were missing relevant clinical or
269 Patients
were excluded if they were not English speakers, were no
270 Articles
were excluded if they were not in English, reported fewe
271 Studies
were excluded if they were not RCTs, the antibiotics in
272 Articles
were excluded if they were not relevant, or were perform
273 Patients
were excluded if they were older than 18 years at diagno
274 Trials
were excluded if they were phase 1, enrolled less than 1
275 Children
were excluded if they were pregnant or an ICP monitor wa
276 Participants
were excluded if they were pregnant, breastfeeding, taki
277 addition to the inclusion criteria, patients
were excluded if they were pregnant, coinfected with HIV
278 Patients
were excluded if they were pregnant, had diagnosed hypop
279 Patients
were excluded if they were receiving a non-MEK inhibitor
280 Patients
were excluded if they were referred for research, cytoge
281 Patients
were excluded if they were refractory to previous treatm
282 Studies
were excluded if they were reporting: palliative care ex
283 Studies
were excluded if they were review articles, editorials,
284 Studies
were excluded if they were review articles, retracted, o
285 Patients
were excluded if they were taking a higher statin dose i
286 Patients
were excluded if they were taking or expected to receive
287 Patients
were excluded if they were too well, too sick (in the se
288 Patients
were excluded if they were treated for medical disorders
289 Individuals
were excluded if they were treated with antipsychotics (
290 Household contacts
were excluded if they were unlikely to attend study visi
291 Women
were excluded if they were vegetarians, consumed soy pro
292 In Bangladesh and Indonesia, patients
were excluded if they were younger than 1 year, whereas
293 Patients
were excluded if they were younger than 18 years, had a
294 Patients
were excluded if they were younger than 18 years, had a
295 Patients
were excluded if they were younger than 18 years, pregna
296 Patients
were excluded if they were younger than 18 years, the fi
297 er than 1 year, whereas in Ethiopia patients
were excluded if they were younger than 18 years.
298 The VFs
were excluded if visual acuity <20/400 or loss of >=2 Sn
299 Tests
were excluded if visual acuity was <= 20/400 or loss of